Header cover image

Taiwanese Pharmaceuticals & Biotech Breakout Stocks

Results

1

1 new

Stocks where the price continues to rise after more than a year of consistent gains.

1 companies

ACRO Biomedical

Market Cap: NT$9.1b

Develops medical-grade regenerative biomaterials.

New

6748

NT$127.50

7D

70.0%

1Y

236.9%